Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05790746
Other study ID # OMU KAEK 11.07.2019/533
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2019
Est. completion date September 9, 2020

Study information

Verified date March 2023
Source Samsun Liv Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose: The aim of the study is to identify a precise learning curve for pure retroperitoneoscopic donor nephrectomy (RDN). Methods: Data from 172 consecutive kidney donors who underwent pure RDN between January 2010 and July 2019 were prospectively collected and evaluated. CUSUM (cumulative sum) analysis was used for testing the operation time. Changepoints were determined by using the R program and BinSeg method. The cohort was divided into three groups. Group 1 refers to competence including the first 10 cases, group 2: 11- 48 cases as proficiency, and group 3: the subsequent 124 cases as expert level. Continuous variables were evaluated using one-way ANOVA, and categorical data were evaluated using the Chi-square test


Description:

The prospectively collected data of 172 consecutive kidney donors undergoing pure RDN for transplantation at Ondokuz Mayıs University from January 2010 to July 2019 were evaluated retrospectively. Tc-99m mercaptoacetyltriglycine (MAG3) renal scintigraphy was performed to evaluate for split renal function. Three-dimensional computed tomography was performed to evaluate kidney anatomy and vasculature. The final decision for the laterality of surgery was based on the conviction that the better kidney remains with the donor. If both kidneys have equal functional characteristics, the left kidney or the kidney with simpler vascular anatomy was procured based on the transplantation medical review board's decision. The demographic data including age, gender, body mass index (BMI), preoperative renal function, number of renal arteries and veins were recorded. Perioperative variables such as operation time (OT), warm ischemia time (WIT), estimated blood loss (EBL), perioperative and postoperative complications were also recorded. Furthermore, the outcomes of renal recipients including graft function, complications and follow-up were recorded as well. In our previously published article provides a thorough description of the surgical procedure and details for the right and left sides of pure RDN. All RNDs were performed by a single surgeon with experience in retroperitoneoscopic laparoscopic surgery and kidney transplantation. Learning curve analysis The CUSUM analysis and BinSeg (Binary Segmentation) method Although the CUSUM analysis was first built to evaluate industrial sector performance, it has been adopted in medicine to interpret many surgical techniques learning curve. In a timeline, it calculates the sum of the existing differences between individual operation times and the mean of all operation times. Its main use of in medicine is that calculates the sum of the existing differences between individual operation times and the mean of all operation times in a timeline. The next step is to identify significant change points to determine the development. The "changepoint" package was used in the R program to determine the change points. The changepoints were determined according to the mean variation. BinSeg methods were used to identify two exchange points. Penalty methods were not used to determine surgical time change points. The "Normal" method was used as the test statistic for the surgical time. According to the learning curve analysis methods that are mentioned above, the whole cohort was divided into three groups. Inspired by the Dreyfus model of skill acquisition in the naming of the groups. Thus, group 1 represents competence, group 2 is proficiency level, and group 3 is the expert level.


Recruitment information / eligibility

Status Completed
Enrollment 172
Est. completion date September 9, 2020
Est. primary completion date November 3, 2019
Accepts healthy volunteers No
Gender All
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria: - patients with complete data - patients with consent - Patients > 18 year-old - The surgeries performed by the surgeon EO - Patients who underwent retroperitoneoscopic donor nephrectomy at Ondokuz Mayis University, Department of Urology Exclusion Criteria: - Missing data - patients without consent - patients who underwent open of transperitoneal laparoscopic donor nephrectomy

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Ondokuz Mayis University, Department of Urology Samsun

Sponsors (1)

Lead Sponsor Collaborator
Samsun Liv Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Kudsi OY, Gokcal F, Bou-Ayash N, Crawford AS. Learning curve of robotic transversus abdominis release in ventral hernia repair: a cumulative sum (CUSUM) analysis. Surg Endosc. 2022 May;36(5):3480-3488. doi: 10.1007/s00464-021-08669-7. Epub 2021 Sep 7. — View Citation

Pal BC, Modi PR, Rizvi SJ, Chauhan R, Kumar S, Nagarajan R, Kaushal D, Kute VB, Trivedi HL. The Learning Curve of Pure Retroperitoneoscopic Donor Nephrectomy. Int J Organ Transplant Med. 2017;8(4):180-185. Epub 2017 Nov 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Opertaion time From first trocar incision to closure of all incisions during the surgery (minute)
Primary Estimeted blood loss perioperative estimated blood loss during the surgery (mL)
Primary warm ischemia time Its starts when the renal artery and vein are controlled and it ends when reperfusion of the graft kidney starts on the back table during the surgery (second)
Secondary Learning curve Number of cases required to achieve reduction in operative time, warm ischemia time, and estimated blood loss. through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Withdrawn NCT05811468 - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Active, not recruiting NCT04166149 - Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA
Completed NCT03723668 - Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France
Recruiting NCT03737604 - TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant Phase 4
Completed NCT03765203 - Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients N/A
Completed NCT05809440 - Effectiveness of 20m-MB in KTR Symptom Control N/A
Enrolling by invitation NCT04491227 - Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Not yet recruiting NCT06396702 - EASE-SOT Pilot Study N/A
Recruiting NCT03310905 - Abdominal Wall Transplant N/A
Recruiting NCT05613010 - Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant N/A
Recruiting NCT06263257 - The Effect of Mandala Therapy on Anxiety and Comfort in Kidney Transplant Recipients N/A
Completed NCT04715412 - Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients N/A
Active, not recruiting NCT05449496 - Dietary Intervention to Improve Kidney Transplant Outcomes N/A
Not yet recruiting NCT06089473 - Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates N/A
Withdrawn NCT04473924 - Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk Phase 2
Recruiting NCT04619732 - Real-time Monitoring of Kidney Grafts on Hypothermic Machine Perfusion N/A
Completed NCT03760263 - Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus Phase 4
Active, not recruiting NCT03380962 - Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Phase 1/Phase 2
Active, not recruiting NCT03436368 - Continuous Spinal Anesthesia in Renal Transplantation N/A
Not yet recruiting NCT03322709 - Minimally Invasive Kidney Transplantation N/A

External Links